The MLLT3 gene helps control when other genes turn on and off, especially during early development and in blood-forming cells. This gene plays an important role in keeping cell growth and maturation on track. If the MLLT3 gene does not work as expected, it can be linked to developmental delay, learning difficulties, and growth differences, and changes that join it to another gene in blood cells can contribute to some leukemias. MLLT3 is mainly known in medicine rather than popular culture.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions they can use to make molecules or manage processes in the body. Some genes carry the code for proteins, which are the parts of cells that do much of the work. Others mainly help regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
MLLT3Gene function
What if the gene works
The MLLT3 gene helps control when other genes turn on. It is especially important in blood stem cells, where it supports normal growth and the supply of new blood cells.
Risk
What if the gene does not work
Changes in the MLLT3 gene can be linked to developmental delay, speech and learning difficulties, and sometimes growth or brain development differences. Effects may range from milder to more marked. Acquired MLLT3 rearrangements also occur in some leukemias.
Treatment
What does that mean for your treatment
No MLLT3-specific treatment or management approach is currently established in clinical guidelines for a pathogenic or loss-of-function variant in the MLLT3 gene. The MLLT3 gene is mainly being studied in leukemia when it becomes part of a fusion gene, where it may help classify disease and support research on future targeted therapies rather than current routine drug choice.
Conditions associated with MLLT3
Gene function
What if the gene works
In many cells, the MLLT3 gene helps coordinate how DNA instructions are read, especially in early blood-forming cells. Its protein works in the nucleus with other proteins that manage gene activity as cells grow and specialize. This supports normal blood cell development and steady cell renewal.
The MLLT3 gene helps switch on selected genes at the right time. This keeps cell programs organized as cells grow, divide, and take on specific roles.
Its protein supports the step where cells make RNA working copies from DNA so gene instructions can be carried forward. This helps long or complex genes be read more smoothly and completely.
A key part of what the MLLT3 gene does in blood stem cells is helping them keep their renewal program while still allowing healthy maturation. This helps your body maintain a steady supply of new blood cells over time.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. Variants are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions to a greater degree and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MLLT3 gene can alter the protein’s shape, reduce how much a cell makes, or disrupt binding to partner proteins that regulate gene activity. This is how MLLT3 gene variants affect cell function. Milder changes may partly reduce activity, while more severe variants can leave little or no working protein. Some rearrangements join MLLT3 to another gene, creating a fusion protein (one protein made from two genes).
How variants are linked to conditions
Changes involving the MLLT3 gene are best known in certain blood cancers. Acquired rearrangements involving the MLLT3 gene, especially the KMT2A::MLLT3 fusion, are linked to some cases of acute myeloid leukemia and acute lymphoblastic leukemia and can help define a leukemia subtype. These changes usually arise in blood-forming cells during life rather than being inherited.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widespread across the population. Most do not directly affect health and simply reflect natural human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to MLLT3. If you have a change in the MLLT3 gene or a family history linked to it, a doctor or genetic counselor can help explain what it may mean for your personal risk.
Inheritance of MLLT3 variants
For families looking into how MLLT3 gene variants are inherited, there is not yet a broadly confirmed disease specific inheritance pattern used in routine clinical genetics for this gene. Much of the well known MLLT3-related change seen in medicine involves changes that arise in blood cells during life rather than being passed through a family. The MLLT3 gene is located on chromosome 9, which is an autosome, so each person inherits one copy from each parent.
What does my MLLT3 result mean for my family?
For MLLT3, the family impact depends on which kind of result was found. Rare inherited changes in this gene linked to a developmental condition are usually in a dominant pattern, so close relatives may also carry the same change and may choose to discuss testing; some cases can also happen for the first time in one family. If the result involves a leukemia-related gene change found only in tumor or blood cells, it usually does not mean relatives are at risk.
Genetic information
Genetic testing
How you find out about variants
Testing for MLLT3 gene variants usually uses a blood sample or saliva sample. The lab reads the DNA code in the MLLT3 gene and may also look for larger missing, extra, or rearranged pieces. Results can show whether a variant is present and whether it is known to be linked with a genetic condition.
When should I consider getting a genetic test?
Genetic testing may be considered if you or your child is being checked for certain acute leukemias, because changes involving the MLLT3 gene can help confirm the exact type of blood cancer and guide care. This testing is usually done on leukemia cells, not as an inherited family test.
A genetic result is only one part of your health story
Genetic results can provide meaningful insight, but how much they explain depends on the condition and the kind of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles a medicine, so the same treatment may work differently from one person to another. Some people break down a drug more slowly or more quickly, which can change how strongly it works or how likely side effects are. This kind of difference is common and is one reason medication response can vary even when people take the same drug.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medication. It looks at gene and drug patterns to help explain why treatment effects can vary from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This understanding can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the MLLT3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or response. If you have concerns about side effects, how well a treatment is working, or what this result means for your overall health, it is best to discuss them with your doctor.
History
The MLLT3 gene entered medical research through studies of acute leukemia, especially cases with a chromosome swap called t(9;11). First described in the scientific literature as part of early genetics, this finding helped researchers connect specific chromosome changes with distinct leukemia patterns. MLLT3 became known by the older name AF9 in that early work, and that name still appears in some medical papers. From these first observations, research expanded steadily as scientists mapped the gene more precisely and linked it to recurrent leukemia-related rearrangements. Over time, this work helped shape modern cancer genetics by showing how chromosome changes can define subtypes of blood cancer.